NeuroOne CFO Ron McClurg to Retire June 30, Chris Volker Named Successor
NMTC•NeuroOne CFO Ron McClurg will retire effective June 30, 2026 and will remain as Senior Advisor through December 31, 2026 to support transition. Chief Operating Officer Chris Volker, a CFA charterholder with over 25 years of medtech leadership, will permanently assume CFO duties while David Wambeke becomes Chief Business Officer.
1. CFO Transition Plan
Ron McClurg will step down as Chief Financial Officer on June 30, 2026 and will remain with NeuroOne through December 31, 2026 as a Senior Advisor to ensure a seamless handover of financial responsibilities.
2. New CFO Profile and Impact
Chris Volker, currently Chief Operating Officer, will assume the CFO role permanently on July 1, 2026. Volker brings over 25 years of operational and financial leadership in the medical device industry, including senior roles at Abbott, Cardiovascular Systems, Inc., and St. Jude Medical, and holds both an MBA from Wharton and the CFA designation.
3. Chief Business Officer Appointment
David Wambeke, newly appointed Chief Business Officer, will take over Volker’s former COO responsibilities, focusing on commercial operations and business development to support NeuroOne’s growth strategy.
